Itchy skin linked to hepatitis C infection

November 2, 1998
NEW YORK (Reuters Health) -- In some cases, itchy skin may be the first symptom of chronic hepatitis C infection, a study suggests.

In a study of 19 patients referred for treatment for severely itchy skin, 4 (21%) were found to have hepatitis C, according to a report in the October issue of Digestive Diseases and Sciences. And another study of 122 hepatitis C patients showed that about 4% had severe itchy skin, known medically as pruritus.

Hepatitis C is a viral infection of the liver that can lead to liver failure and the need for liver transplant. Dr. Jay H. Hoofnagle, of the National Cancer Institute, Bethesda, Maryland, and colleagues took a closer look at eight of the patients from the studies, who were aged 35 to 68, had been diagnosed with hepatitis from 1 to 20 years previously, and had pruritus as the major or first symptom of the disease.

Liver biopsies revealed that all patients had liver damage similar to that seen in cholestasis, a liver disease caused by stagnation of the bile in the bile ducts. Itchy skin is a ommon side effect of cholestasis.

The authors conclude that ``pruritus may be the dominant symptom in patients with chronic hepatitis C and, if severe enough, may be a factor in making a decision regarding liver transplantation.''

SOURCE: Digestive Diseases and Sciences, 1998;43:2177-2183.

Advertisement

Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....

Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...

Popular Illegal Drug Extra Harmful with HCV
Scientists have found a popular street drug worsens Hepatitis C infection in two worrisome ways....

More Hep C articles ...